Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Significant Decline in Short Interest

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 15,401 shares, a decline of 79.5% from the May 31st total of 74,992 shares. Based on an average trading volume of 457,076 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a report on Monday, May 25th. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR presently has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 2.0%

Shares of SGIOY traded up $0.17 on Friday, reaching $8.52. 272,160 shares of the company’s stock were exchanged, compared to its average volume of 206,524. The business has a 50 day moving average price of $9.30 and a two-hundred day moving average price of $9.89. Shionogi & Co., Ltd. Unsponsored ADR has a 12 month low of $7.65 and a 12 month high of $12.00. The stock has a market capitalization of $14.50 billion, a P/E ratio of 10.65, a price-to-earnings-growth ratio of 3.27 and a beta of 0.08. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. The firm had revenue of $881.71 million for the quarter, compared to analysts’ expectations of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 13.56%. Research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 earnings per share for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.